Arkolith/Insider Trading/CALA/Form 4

Orford Keith

DirectorCalithera Biosciences, Inc. (CALA) · full profile →Form 4 · filed Nov 9, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$44K
Net Open-Market Flow
-$44K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 9, 2021Sell(S)52K$0.84$44K144K
Nov 5, 2021Grant(A)30K—$0196K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-043693) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML